论文部分内容阅读
目的探讨支气管哮喘并过敏性鼻炎的临床疗效。方法回顾分析82例患者的临床资料。结果两组治疗前后哮喘控制测试(ACT)评分情况两组患者治疗后哮喘控制测试(ACT)评分均较治疗前明显提高,具有统计学意义(P<0.05)。结论布地奈德喷鼻剂与舒利迭吸入剂联合治疗比单用舒利迭吸入剂治疗能显著提高临床疗效,而单用舒利迭吸入剂不能改善患者的鼻炎症状指数,因此,过敏性鼻炎-哮喘综合征需要对上下呼吸道同时进行联合治疗,才能更好地提高患者的生存质量。
Objective To investigate the clinical effects of bronchial asthma and allergic rhinitis. Methods The clinical data of 82 patients were retrospectively analyzed. Results The scores of ACT before and after treatment in both groups were significantly higher than those before treatment (P <0.05). The ACT scores of both groups after treatment were significantly higher (P <0.05). Conclusions The combination of budesonide nasal spray and seretide inhalation can significantly improve the clinical curative effect than the single use of sulpiride inhalation, while the single inhalation of sulpiride can not improve the rhinitis symptom index of patients. Therefore, allergic Rhinitis - asthma syndrome need to be treated simultaneously with the upper and lower respiratory tract, in order to better improve the quality of life of patients.